nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Asthma—Epirubicin—liver cancer	0.000657	0.000953	CcSEcCtD
Topiramate—Dysphagia—Epirubicin—liver cancer	0.000657	0.000953	CcSEcCtD
Topiramate—Dehydration—Doxorubicin—liver cancer	0.000655	0.000949	CcSEcCtD
Topiramate—Eosinophilia—Epirubicin—liver cancer	0.000651	0.000944	CcSEcCtD
Topiramate—Liver function test abnormal—Doxorubicin—liver cancer	0.00065	0.000942	CcSEcCtD
Topiramate—Pancreatitis—Epirubicin—liver cancer	0.000645	0.000934	CcSEcCtD
Topiramate—Vomiting—Sorafenib—liver cancer	0.000643	0.000932	CcSEcCtD
Topiramate—Orthostatic hypotension—Doxorubicin—liver cancer	0.000643	0.000932	CcSEcCtD
Topiramate—Abdominal pain upper—Doxorubicin—liver cancer	0.000643	0.000932	CcSEcCtD
Topiramate—Hypokalaemia—Doxorubicin—liver cancer	0.000641	0.000929	CcSEcCtD
Topiramate—Angina pectoris—Epirubicin—liver cancer	0.00064	0.000928	CcSEcCtD
Topiramate—Rash—Sorafenib—liver cancer	0.000638	0.000925	CcSEcCtD
Topiramate—Dermatitis—Sorafenib—liver cancer	0.000637	0.000924	CcSEcCtD
Topiramate—Breast disorder—Doxorubicin—liver cancer	0.000636	0.000922	CcSEcCtD
Topiramate—Toxic epidermal necrolysis—Doxorubicin—liver cancer	0.000634	0.000919	CcSEcCtD
Topiramate—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000634	0.000919	CcSEcCtD
Topiramate—Headache—Sorafenib—liver cancer	0.000634	0.000919	CcSEcCtD
Topiramate—Bronchitis—Epirubicin—liver cancer	0.000632	0.000917	CcSEcCtD
Topiramate—Nasopharyngitis—Doxorubicin—liver cancer	0.000629	0.000912	CcSEcCtD
Topiramate—Pancytopenia—Epirubicin—liver cancer	0.000624	0.000905	CcSEcCtD
Topiramate—Gastritis—Doxorubicin—liver cancer	0.000623	0.000903	CcSEcCtD
Topiramate—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000621	0.0009	CcSEcCtD
Topiramate—Muscular weakness—Doxorubicin—liver cancer	0.000621	0.0009	CcSEcCtD
Topiramate—Dysuria—Epirubicin—liver cancer	0.000615	0.000891	CcSEcCtD
Topiramate—Neutropenia—Epirubicin—liver cancer	0.000615	0.000891	CcSEcCtD
Topiramate—Abdominal distension—Doxorubicin—liver cancer	0.000612	0.000888	CcSEcCtD
Topiramate—Upper respiratory tract infection—Epirubicin—liver cancer	0.000611	0.000886	CcSEcCtD
Topiramate—Asthma—Doxorubicin—liver cancer	0.000608	0.000882	CcSEcCtD
Topiramate—Dysphagia—Doxorubicin—liver cancer	0.000608	0.000882	CcSEcCtD
Topiramate—Pollakiuria—Epirubicin—liver cancer	0.000607	0.00088	CcSEcCtD
Topiramate—Eosinophilia—Doxorubicin—liver cancer	0.000602	0.000873	CcSEcCtD
Topiramate—Nausea—Sorafenib—liver cancer	0.000601	0.000871	CcSEcCtD
Topiramate—Photosensitivity reaction—Epirubicin—liver cancer	0.0006	0.00087	CcSEcCtD
Topiramate—Weight increased—Epirubicin—liver cancer	0.000598	0.000867	CcSEcCtD
Topiramate—Pancreatitis—Doxorubicin—liver cancer	0.000596	0.000865	CcSEcCtD
Topiramate—Weight decreased—Epirubicin—liver cancer	0.000595	0.000862	CcSEcCtD
Topiramate—Hyperglycaemia—Epirubicin—liver cancer	0.000593	0.00086	CcSEcCtD
Topiramate—Angina pectoris—Doxorubicin—liver cancer	0.000593	0.000859	CcSEcCtD
Topiramate—Pneumonia—Epirubicin—liver cancer	0.00059	0.000855	CcSEcCtD
Topiramate—Infestation NOS—Epirubicin—liver cancer	0.000586	0.00085	CcSEcCtD
Topiramate—Infestation—Epirubicin—liver cancer	0.000586	0.00085	CcSEcCtD
Topiramate—Bronchitis—Doxorubicin—liver cancer	0.000585	0.000848	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Epirubicin—liver cancer	0.000581	0.000842	CcSEcCtD
Topiramate—Pancytopenia—Doxorubicin—liver cancer	0.000578	0.000837	CcSEcCtD
Topiramate—Renal failure—Epirubicin—liver cancer	0.000576	0.000835	CcSEcCtD
Topiramate—Neuropathy peripheral—Epirubicin—liver cancer	0.000575	0.000833	CcSEcCtD
Topiramate—Stomatitis—Epirubicin—liver cancer	0.000571	0.000828	CcSEcCtD
Topiramate—Conjunctivitis—Epirubicin—liver cancer	0.00057	0.000826	CcSEcCtD
Topiramate—Urinary tract infection—Epirubicin—liver cancer	0.00057	0.000826	CcSEcCtD
Topiramate—Dysuria—Doxorubicin—liver cancer	0.000569	0.000825	CcSEcCtD
Topiramate—Neutropenia—Doxorubicin—liver cancer	0.000569	0.000825	CcSEcCtD
Topiramate—Upper respiratory tract infection—Doxorubicin—liver cancer	0.000565	0.00082	CcSEcCtD
Topiramate—Pollakiuria—Doxorubicin—liver cancer	0.000562	0.000815	CcSEcCtD
Topiramate—Haematuria—Epirubicin—liver cancer	0.000559	0.00081	CcSEcCtD
Topiramate—Photosensitivity reaction—Doxorubicin—liver cancer	0.000555	0.000805	CcSEcCtD
Topiramate—Weight increased—Doxorubicin—liver cancer	0.000554	0.000803	CcSEcCtD
Topiramate—Epistaxis—Epirubicin—liver cancer	0.000553	0.000802	CcSEcCtD
Topiramate—Weight decreased—Doxorubicin—liver cancer	0.00055	0.000798	CcSEcCtD
Topiramate—Sinusitis—Epirubicin—liver cancer	0.00055	0.000797	CcSEcCtD
Topiramate—Hyperglycaemia—Doxorubicin—liver cancer	0.000549	0.000795	CcSEcCtD
Topiramate—Agranulocytosis—Epirubicin—liver cancer	0.000547	0.000793	CcSEcCtD
Topiramate—Pneumonia—Doxorubicin—liver cancer	0.000546	0.000791	CcSEcCtD
Topiramate—Infestation NOS—Doxorubicin—liver cancer	0.000542	0.000786	CcSEcCtD
Topiramate—Infestation—Doxorubicin—liver cancer	0.000542	0.000786	CcSEcCtD
Topiramate—Stevens-Johnson syndrome—Doxorubicin—liver cancer	0.000538	0.00078	CcSEcCtD
Topiramate—Bradycardia—Epirubicin—liver cancer	0.000536	0.000777	CcSEcCtD
Topiramate—Renal failure—Doxorubicin—liver cancer	0.000533	0.000773	CcSEcCtD
Topiramate—Neuropathy peripheral—Doxorubicin—liver cancer	0.000532	0.000771	CcSEcCtD
Topiramate—Haemoglobin—Epirubicin—liver cancer	0.000529	0.000767	CcSEcCtD
Topiramate—Stomatitis—Doxorubicin—liver cancer	0.000529	0.000766	CcSEcCtD
Topiramate—Rhinitis—Epirubicin—liver cancer	0.000528	0.000765	CcSEcCtD
Topiramate—Conjunctivitis—Doxorubicin—liver cancer	0.000527	0.000764	CcSEcCtD
Topiramate—Urinary tract infection—Doxorubicin—liver cancer	0.000527	0.000764	CcSEcCtD
Topiramate—Hepatitis—Epirubicin—liver cancer	0.000526	0.000763	CcSEcCtD
Topiramate—Haemorrhage—Epirubicin—liver cancer	0.000526	0.000763	CcSEcCtD
Topiramate—Hypoaesthesia—Epirubicin—liver cancer	0.000524	0.000759	CcSEcCtD
Topiramate—Pharyngitis—Epirubicin—liver cancer	0.000522	0.000757	CcSEcCtD
Topiramate—Urinary tract disorder—Epirubicin—liver cancer	0.00052	0.000753	CcSEcCtD
Topiramate—Oedema peripheral—Epirubicin—liver cancer	0.000518	0.000752	CcSEcCtD
Topiramate—Haematuria—Doxorubicin—liver cancer	0.000517	0.00075	CcSEcCtD
Topiramate—Connective tissue disorder—Epirubicin—liver cancer	0.000517	0.00075	CcSEcCtD
Topiramate—Urethral disorder—Epirubicin—liver cancer	0.000516	0.000748	CcSEcCtD
Topiramate—Epistaxis—Doxorubicin—liver cancer	0.000512	0.000742	CcSEcCtD
Topiramate—Sinusitis—Doxorubicin—liver cancer	0.000509	0.000738	CcSEcCtD
Topiramate—Visual impairment—Epirubicin—liver cancer	0.000507	0.000735	CcSEcCtD
Topiramate—Agranulocytosis—Doxorubicin—liver cancer	0.000506	0.000734	CcSEcCtD
Topiramate—Erythema multiforme—Epirubicin—liver cancer	0.000498	0.000721	CcSEcCtD
Topiramate—Bradycardia—Doxorubicin—liver cancer	0.000496	0.000719	CcSEcCtD
Topiramate—Eye disorder—Epirubicin—liver cancer	0.000492	0.000713	CcSEcCtD
Topiramate—Tinnitus—Epirubicin—liver cancer	0.000491	0.000711	CcSEcCtD
Topiramate—Haemoglobin—Doxorubicin—liver cancer	0.000489	0.000709	CcSEcCtD
Topiramate—Flushing—Epirubicin—liver cancer	0.000488	0.000708	CcSEcCtD
Topiramate—Cardiac disorder—Epirubicin—liver cancer	0.000488	0.000708	CcSEcCtD
Topiramate—Rhinitis—Doxorubicin—liver cancer	0.000488	0.000708	CcSEcCtD
Topiramate—Haemorrhage—Doxorubicin—liver cancer	0.000487	0.000706	CcSEcCtD
Topiramate—Hepatitis—Doxorubicin—liver cancer	0.000487	0.000706	CcSEcCtD
Topiramate—Hypoaesthesia—Doxorubicin—liver cancer	0.000484	0.000702	CcSEcCtD
Topiramate—Pharyngitis—Doxorubicin—liver cancer	0.000483	0.000701	CcSEcCtD
Topiramate—Urinary tract disorder—Doxorubicin—liver cancer	0.000481	0.000697	CcSEcCtD
Topiramate—Oedema peripheral—Doxorubicin—liver cancer	0.00048	0.000695	CcSEcCtD
Topiramate—Connective tissue disorder—Doxorubicin—liver cancer	0.000478	0.000694	CcSEcCtD
Topiramate—Angiopathy—Epirubicin—liver cancer	0.000477	0.000692	CcSEcCtD
Topiramate—Urethral disorder—Doxorubicin—liver cancer	0.000477	0.000692	CcSEcCtD
Topiramate—Immune system disorder—Epirubicin—liver cancer	0.000475	0.000689	CcSEcCtD
Topiramate—Mediastinal disorder—Epirubicin—liver cancer	0.000474	0.000688	CcSEcCtD
Topiramate—Chills—Epirubicin—liver cancer	0.000472	0.000684	CcSEcCtD
Topiramate—Visual impairment—Doxorubicin—liver cancer	0.000469	0.00068	CcSEcCtD
Topiramate—Alopecia—Epirubicin—liver cancer	0.000465	0.000674	CcSEcCtD
Topiramate—Mental disorder—Epirubicin—liver cancer	0.000461	0.000668	CcSEcCtD
Topiramate—Erythema multiforme—Doxorubicin—liver cancer	0.00046	0.000667	CcSEcCtD
Topiramate—Erythema—Epirubicin—liver cancer	0.000458	0.000664	CcSEcCtD
Topiramate—Malnutrition—Epirubicin—liver cancer	0.000458	0.000664	CcSEcCtD
Topiramate—Eye disorder—Doxorubicin—liver cancer	0.000455	0.00066	CcSEcCtD
Topiramate—Tinnitus—Doxorubicin—liver cancer	0.000454	0.000658	CcSEcCtD
Topiramate—Flushing—Doxorubicin—liver cancer	0.000452	0.000655	CcSEcCtD
Topiramate—Cardiac disorder—Doxorubicin—liver cancer	0.000452	0.000655	CcSEcCtD
Topiramate—Flatulence—Epirubicin—liver cancer	0.000451	0.000654	CcSEcCtD
Topiramate—Tension—Epirubicin—liver cancer	0.000449	0.000652	CcSEcCtD
Topiramate—Dysgeusia—Epirubicin—liver cancer	0.000449	0.00065	CcSEcCtD
Topiramate—Nervousness—Epirubicin—liver cancer	0.000445	0.000645	CcSEcCtD
Topiramate—Back pain—Epirubicin—liver cancer	0.000443	0.000642	CcSEcCtD
Topiramate—Angiopathy—Doxorubicin—liver cancer	0.000442	0.00064	CcSEcCtD
Topiramate—Muscle spasms—Epirubicin—liver cancer	0.00044	0.000638	CcSEcCtD
Topiramate—Immune system disorder—Doxorubicin—liver cancer	0.00044	0.000638	CcSEcCtD
Topiramate—Mediastinal disorder—Doxorubicin—liver cancer	0.000439	0.000636	CcSEcCtD
Topiramate—Chills—Doxorubicin—liver cancer	0.000437	0.000633	CcSEcCtD
Topiramate—Vision blurred—Epirubicin—liver cancer	0.000432	0.000626	CcSEcCtD
Topiramate—Alopecia—Doxorubicin—liver cancer	0.00043	0.000624	CcSEcCtD
Topiramate—Mental disorder—Doxorubicin—liver cancer	0.000427	0.000618	CcSEcCtD
Topiramate—Ill-defined disorder—Epirubicin—liver cancer	0.000425	0.000616	CcSEcCtD
Topiramate—Erythema—Doxorubicin—liver cancer	0.000424	0.000614	CcSEcCtD
Topiramate—Malnutrition—Doxorubicin—liver cancer	0.000424	0.000614	CcSEcCtD
Topiramate—Anaemia—Epirubicin—liver cancer	0.000423	0.000614	CcSEcCtD
Topiramate—Agitation—Epirubicin—liver cancer	0.000421	0.00061	CcSEcCtD
Topiramate—Flatulence—Doxorubicin—liver cancer	0.000418	0.000605	CcSEcCtD
Topiramate—Tension—Doxorubicin—liver cancer	0.000416	0.000603	CcSEcCtD
Topiramate—Dysgeusia—Doxorubicin—liver cancer	0.000415	0.000602	CcSEcCtD
Topiramate—Malaise—Epirubicin—liver cancer	0.000413	0.000599	CcSEcCtD
Topiramate—Nervousness—Doxorubicin—liver cancer	0.000412	0.000597	CcSEcCtD
Topiramate—Vertigo—Epirubicin—liver cancer	0.000412	0.000597	CcSEcCtD
Topiramate—Syncope—Epirubicin—liver cancer	0.000411	0.000596	CcSEcCtD
Topiramate—Leukopenia—Epirubicin—liver cancer	0.00041	0.000594	CcSEcCtD
Topiramate—Back pain—Doxorubicin—liver cancer	0.00041	0.000594	CcSEcCtD
Topiramate—Muscle spasms—Doxorubicin—liver cancer	0.000407	0.000591	CcSEcCtD
Topiramate—Palpitations—Epirubicin—liver cancer	0.000405	0.000587	CcSEcCtD
Topiramate—Loss of consciousness—Epirubicin—liver cancer	0.000403	0.000584	CcSEcCtD
Topiramate—Cough—Epirubicin—liver cancer	0.0004	0.000579	CcSEcCtD
Topiramate—Vision blurred—Doxorubicin—liver cancer	0.000399	0.000579	CcSEcCtD
Topiramate—Convulsion—Epirubicin—liver cancer	0.000397	0.000575	CcSEcCtD
Topiramate—Hypertension—Epirubicin—liver cancer	0.000395	0.000573	CcSEcCtD
Topiramate—Ill-defined disorder—Doxorubicin—liver cancer	0.000393	0.00057	CcSEcCtD
Topiramate—Anaemia—Doxorubicin—liver cancer	0.000392	0.000568	CcSEcCtD
Topiramate—Myalgia—Epirubicin—liver cancer	0.00039	0.000565	CcSEcCtD
Topiramate—Arthralgia—Epirubicin—liver cancer	0.00039	0.000565	CcSEcCtD
Topiramate—Chest pain—Epirubicin—liver cancer	0.00039	0.000565	CcSEcCtD
Topiramate—Agitation—Doxorubicin—liver cancer	0.000389	0.000565	CcSEcCtD
Topiramate—Anxiety—Epirubicin—liver cancer	0.000389	0.000563	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.000387	0.000561	CcSEcCtD
Topiramate—Discomfort—Epirubicin—liver cancer	0.000385	0.000559	CcSEcCtD
Topiramate—Malaise—Doxorubicin—liver cancer	0.000382	0.000554	CcSEcCtD
Topiramate—Dry mouth—Epirubicin—liver cancer	0.000381	0.000553	CcSEcCtD
Topiramate—Vertigo—Doxorubicin—liver cancer	0.000381	0.000552	CcSEcCtD
Topiramate—Syncope—Doxorubicin—liver cancer	0.00038	0.000551	CcSEcCtD
Topiramate—Leukopenia—Doxorubicin—liver cancer	0.000379	0.00055	CcSEcCtD
Topiramate—Confusional state—Epirubicin—liver cancer	0.000377	0.000546	CcSEcCtD
Topiramate—Palpitations—Doxorubicin—liver cancer	0.000375	0.000543	CcSEcCtD
Topiramate—Oedema—Epirubicin—liver cancer	0.000374	0.000542	CcSEcCtD
Topiramate—Loss of consciousness—Doxorubicin—liver cancer	0.000373	0.00054	CcSEcCtD
Topiramate—Infection—Epirubicin—liver cancer	0.000371	0.000538	CcSEcCtD
Topiramate—Cough—Doxorubicin—liver cancer	0.00037	0.000536	CcSEcCtD
Topiramate—Shock—Epirubicin—liver cancer	0.000368	0.000533	CcSEcCtD
Topiramate—Convulsion—Doxorubicin—liver cancer	0.000367	0.000532	CcSEcCtD
Topiramate—Nervous system disorder—Epirubicin—liver cancer	0.000367	0.000532	CcSEcCtD
Topiramate—Thrombocytopenia—Epirubicin—liver cancer	0.000366	0.000531	CcSEcCtD
Topiramate—Hypertension—Doxorubicin—liver cancer	0.000366	0.00053	CcSEcCtD
Topiramate—Tachycardia—Epirubicin—liver cancer	0.000365	0.000529	CcSEcCtD
Topiramate—Skin disorder—Epirubicin—liver cancer	0.000363	0.000526	CcSEcCtD
Topiramate—Hyperhidrosis—Epirubicin—liver cancer	0.000361	0.000524	CcSEcCtD
Topiramate—Arthralgia—Doxorubicin—liver cancer	0.000361	0.000523	CcSEcCtD
Topiramate—Chest pain—Doxorubicin—liver cancer	0.000361	0.000523	CcSEcCtD
Topiramate—Myalgia—Doxorubicin—liver cancer	0.000361	0.000523	CcSEcCtD
Topiramate—Anxiety—Doxorubicin—liver cancer	0.00036	0.000521	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000358	0.00052	CcSEcCtD
Topiramate—Discomfort—Doxorubicin—liver cancer	0.000357	0.000517	CcSEcCtD
Topiramate—Anorexia—Epirubicin—liver cancer	0.000356	0.000517	CcSEcCtD
Topiramate—Dry mouth—Doxorubicin—liver cancer	0.000353	0.000512	CcSEcCtD
Topiramate—Hypotension—Epirubicin—liver cancer	0.000349	0.000506	CcSEcCtD
Topiramate—Confusional state—Doxorubicin—liver cancer	0.000349	0.000506	CcSEcCtD
Topiramate—Oedema—Doxorubicin—liver cancer	0.000346	0.000501	CcSEcCtD
Topiramate—Infection—Doxorubicin—liver cancer	0.000344	0.000498	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000341	0.000494	CcSEcCtD
Topiramate—Shock—Doxorubicin—liver cancer	0.00034	0.000493	CcSEcCtD
Topiramate—Nervous system disorder—Doxorubicin—liver cancer	0.000339	0.000492	CcSEcCtD
Topiramate—Thrombocytopenia—Doxorubicin—liver cancer	0.000339	0.000491	CcSEcCtD
Topiramate—Insomnia—Epirubicin—liver cancer	0.000338	0.00049	CcSEcCtD
Topiramate—Tachycardia—Doxorubicin—liver cancer	0.000338	0.000489	CcSEcCtD
Topiramate—Skin disorder—Doxorubicin—liver cancer	0.000336	0.000487	CcSEcCtD
Topiramate—Paraesthesia—Epirubicin—liver cancer	0.000336	0.000487	CcSEcCtD
Topiramate—Hyperhidrosis—Doxorubicin—liver cancer	0.000334	0.000485	CcSEcCtD
Topiramate—Dyspnoea—Epirubicin—liver cancer	0.000333	0.000483	CcSEcCtD
Topiramate—Somnolence—Epirubicin—liver cancer	0.000332	0.000482	CcSEcCtD
Topiramate—Anorexia—Doxorubicin—liver cancer	0.00033	0.000478	CcSEcCtD
Topiramate—Dyspepsia—Epirubicin—liver cancer	0.000329	0.000477	CcSEcCtD
Topiramate—Decreased appetite—Epirubicin—liver cancer	0.000325	0.000471	CcSEcCtD
Topiramate—Hypotension—Doxorubicin—liver cancer	0.000323	0.000469	CcSEcCtD
Topiramate—Gastrointestinal disorder—Epirubicin—liver cancer	0.000323	0.000468	CcSEcCtD
Topiramate—Fatigue—Epirubicin—liver cancer	0.000322	0.000467	CcSEcCtD
Topiramate—Pain—Epirubicin—liver cancer	0.00032	0.000463	CcSEcCtD
Topiramate—Constipation—Epirubicin—liver cancer	0.00032	0.000463	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000315	0.000457	CcSEcCtD
Topiramate—Insomnia—Doxorubicin—liver cancer	0.000313	0.000454	CcSEcCtD
Topiramate—Paraesthesia—Doxorubicin—liver cancer	0.000311	0.00045	CcSEcCtD
Topiramate—Dyspnoea—Doxorubicin—liver cancer	0.000308	0.000447	CcSEcCtD
Topiramate—Feeling abnormal—Epirubicin—liver cancer	0.000308	0.000447	CcSEcCtD
Topiramate—Somnolence—Doxorubicin—liver cancer	0.000308	0.000446	CcSEcCtD
Topiramate—Gastrointestinal pain—Epirubicin—liver cancer	0.000306	0.000443	CcSEcCtD
Topiramate—Dyspepsia—Doxorubicin—liver cancer	0.000304	0.000441	CcSEcCtD
Topiramate—Decreased appetite—Doxorubicin—liver cancer	0.000301	0.000436	CcSEcCtD
Topiramate—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000299	0.000433	CcSEcCtD
Topiramate—Fatigue—Doxorubicin—liver cancer	0.000298	0.000432	CcSEcCtD
Topiramate—Urticaria—Epirubicin—liver cancer	0.000297	0.000431	CcSEcCtD
Topiramate—Pain—Doxorubicin—liver cancer	0.000296	0.000429	CcSEcCtD
Topiramate—Constipation—Doxorubicin—liver cancer	0.000296	0.000429	CcSEcCtD
Topiramate—Abdominal pain—Epirubicin—liver cancer	0.000296	0.000428	CcSEcCtD
Topiramate—Body temperature increased—Epirubicin—liver cancer	0.000296	0.000428	CcSEcCtD
Topiramate—Feeling abnormal—Doxorubicin—liver cancer	0.000285	0.000413	CcSEcCtD
Topiramate—Gastrointestinal pain—Doxorubicin—liver cancer	0.000283	0.00041	CcSEcCtD
Topiramate—Hypersensitivity—Epirubicin—liver cancer	0.000275	0.000399	CcSEcCtD
Topiramate—Urticaria—Doxorubicin—liver cancer	0.000275	0.000398	CcSEcCtD
Topiramate—Body temperature increased—Doxorubicin—liver cancer	0.000273	0.000396	CcSEcCtD
Topiramate—Abdominal pain—Doxorubicin—liver cancer	0.000273	0.000396	CcSEcCtD
Topiramate—Asthenia—Epirubicin—liver cancer	0.000268	0.000389	CcSEcCtD
Topiramate—Pruritus—Epirubicin—liver cancer	0.000264	0.000383	CcSEcCtD
Topiramate—Diarrhoea—Epirubicin—liver cancer	0.000256	0.000371	CcSEcCtD
Topiramate—Hypersensitivity—Doxorubicin—liver cancer	0.000255	0.000369	CcSEcCtD
Topiramate—Asthenia—Doxorubicin—liver cancer	0.000248	0.00036	CcSEcCtD
Topiramate—Dizziness—Epirubicin—liver cancer	0.000247	0.000358	CcSEcCtD
Topiramate—Pruritus—Doxorubicin—liver cancer	0.000245	0.000355	CcSEcCtD
Topiramate—Vomiting—Epirubicin—liver cancer	0.000238	0.000345	CcSEcCtD
Topiramate—Diarrhoea—Doxorubicin—liver cancer	0.000237	0.000343	CcSEcCtD
Topiramate—Rash—Epirubicin—liver cancer	0.000236	0.000342	CcSEcCtD
Topiramate—Dermatitis—Epirubicin—liver cancer	0.000235	0.000341	CcSEcCtD
Topiramate—Headache—Epirubicin—liver cancer	0.000234	0.00034	CcSEcCtD
Topiramate—Dizziness—Doxorubicin—liver cancer	0.000229	0.000332	CcSEcCtD
Topiramate—Nausea—Epirubicin—liver cancer	0.000222	0.000322	CcSEcCtD
Topiramate—Vomiting—Doxorubicin—liver cancer	0.00022	0.000319	CcSEcCtD
Topiramate—Rash—Doxorubicin—liver cancer	0.000218	0.000316	CcSEcCtD
Topiramate—Dermatitis—Doxorubicin—liver cancer	0.000218	0.000316	CcSEcCtD
Topiramate—Headache—Doxorubicin—liver cancer	0.000217	0.000314	CcSEcCtD
Topiramate—Nausea—Doxorubicin—liver cancer	0.000205	0.000298	CcSEcCtD
Topiramate—CA7—Metabolism—MTHFR—liver cancer	0.00011	0.000353	CbGpPWpGaD
Topiramate—CA5B—Metabolism—MTHFR—liver cancer	0.00011	0.000353	CbGpPWpGaD
Topiramate—CA12—Metabolism—CYP1A1—liver cancer	0.000109	0.000351	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYCS—liver cancer	0.000108	0.000349	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—MMP9—liver cancer	0.000108	0.000349	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARA—liver cancer	0.000107	0.000346	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARA—liver cancer	0.000107	0.000346	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSMA4—liver cancer	0.000107	0.000344	CbGpPWpGaD
Topiramate—CA9—Metabolism—PSMD10—liver cancer	0.000107	0.000344	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—RAF1—liver cancer	0.000107	0.000344	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—MMP9—liver cancer	0.000107	0.000344	CbGpPWpGaD
Topiramate—CA2—Metabolism—GOT1—liver cancer	0.000106	0.000343	CbGpPWpGaD
Topiramate—CA2—Metabolism—GGT1—liver cancer	0.000106	0.000343	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000106	0.000342	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000106	0.000341	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYCS—liver cancer	0.000104	0.000335	CbGpPWpGaD
Topiramate—CA9—Metabolism—GOT2—liver cancer	0.000104	0.000335	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—TP53—liver cancer	0.000103	0.000332	CbGpPWpGaD
Topiramate—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	0.000102	0.000329	CbGpPWpGaD
Topiramate—CA1—Metabolism—GGT1—liver cancer	0.000102	0.000329	CbGpPWpGaD
Topiramate—CA1—Metabolism—GOT1—liver cancer	0.000102	0.000329	CbGpPWpGaD
Topiramate—CA12—Metabolism—MTHFR—liver cancer	0.000101	0.000327	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP2—liver cancer	0.000101	0.000326	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTP1—liver cancer	9.96e-05	0.000321	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARA—liver cancer	9.95e-05	0.000321	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CG—liver cancer	9.86e-05	0.000318	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CG—liver cancer	9.86e-05	0.000318	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—HRAS—liver cancer	9.84e-05	0.000317	CbGpPWpGaD
Topiramate—CA4—Metabolism—HMOX1—liver cancer	9.83e-05	0.000317	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP2E1—liver cancer	9.76e-05	0.000315	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—VEGFA—liver cancer	9.71e-05	0.000313	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—TNF—liver cancer	9.7e-05	0.000313	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—STAT3—liver cancer	9.62e-05	0.00031	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP2E1—liver cancer	9.61e-05	0.00031	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—VEGFA—liver cancer	9.57e-05	0.000308	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTP1—liver cancer	9.55e-05	0.000308	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PPARG—liver cancer	9.51e-05	0.000307	CbGpPWpGaD
Topiramate—CA6—Metabolism—PPARG—liver cancer	9.51e-05	0.000307	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	9.48e-05	0.000305	CbGpPWpGaD
Topiramate—CA9—Cellular responses to stress—IL6—liver cancer	9.43e-05	0.000304	CbGpPWpGaD
Topiramate—CA2—Metabolism—HMOX1—liver cancer	9.42e-05	0.000304	CbGpPWpGaD
Topiramate—SCN1A—Axon guidance—IL6—liver cancer	9.41e-05	0.000303	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—PPARA—liver cancer	9.33e-05	0.000301	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—RAF1—liver cancer	9.33e-05	0.000301	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—HMOX1—liver cancer	9.23e-05	0.000298	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CG—liver cancer	9.2e-05	0.000297	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CG—liver cancer	9.2e-05	0.000297	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTP1—liver cancer	9.16e-05	0.000295	CbGpPWpGaD
Topiramate—CA4—Metabolism—GSTM1—liver cancer	9.15e-05	0.000295	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYCS—liver cancer	9.13e-05	0.000294	CbGpPWpGaD
Topiramate—CA1—Metabolism—HMOX1—liver cancer	9.03e-05	0.000291	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—RAF1—liver cancer	8.96e-05	0.000289	CbGpPWpGaD
Topiramate—CA9—Metabolism—GOT1—liver cancer	8.96e-05	0.000289	CbGpPWpGaD
Topiramate—CA9—Metabolism—GGT1—liver cancer	8.96e-05	0.000289	CbGpPWpGaD
Topiramate—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—liver cancer	8.92e-05	0.000287	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TGFB1—liver cancer	8.92e-05	0.000287	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PPARG—liver cancer	8.88e-05	0.000286	CbGpPWpGaD
Topiramate—CA7—Metabolism—PPARG—liver cancer	8.88e-05	0.000286	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GGT1—liver cancer	8.82e-05	0.000284	CbGpPWpGaD
Topiramate—CA2—Metabolism—GSTM1—liver cancer	8.78e-05	0.000283	CbGpPWpGaD
Topiramate—CA4—Metabolism—CYP1A1—liver cancer	8.68e-05	0.00028	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CD—liver cancer	8.66e-05	0.000279	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CD—liver cancer	8.66e-05	0.000279	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	8.61e-05	0.000278	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—UGDH—liver cancer	8.59e-05	0.000277	CbGpPWpGaD
Topiramate—CA5A—Metabolism—ALB—liver cancer	8.55e-05	0.000276	CbGpPWpGaD
Topiramate—CA6—Metabolism—ALB—liver cancer	8.55e-05	0.000276	CbGpPWpGaD
Topiramate—GRIA2—Neuronal System—HRAS—liver cancer	8.55e-05	0.000276	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—PPARA—liver cancer	8.54e-05	0.000275	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CG—liver cancer	8.52e-05	0.000275	CbGpPWpGaD
Topiramate—CA1—Metabolism—GSTM1—liver cancer	8.41e-05	0.000271	CbGpPWpGaD
Topiramate—GABRB2—Transmission across Chemical Synapses—HRAS—liver cancer	8.38e-05	0.00027	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—TNF—liver cancer	8.33e-05	0.000268	CbGpPWpGaD
Topiramate—CA2—Metabolism—CYP1A1—liver cancer	8.32e-05	0.000268	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—KRAS—liver cancer	8.26e-05	0.000266	CbGpPWpGaD
Topiramate—CA12—Metabolism—PPARG—liver cancer	8.23e-05	0.000265	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—KRAS—liver cancer	8.14e-05	0.000262	CbGpPWpGaD
Topiramate—CA4—Metabolism—MTHFR—liver cancer	8.09e-05	0.000261	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CD—liver cancer	8.09e-05	0.000261	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CD—liver cancer	8.09e-05	0.000261	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—EPT1—liver cancer	8.07e-05	0.00026	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTP1—liver cancer	8.05e-05	0.000259	CbGpPWpGaD
Topiramate—CA7—Metabolism—ALB—liver cancer	7.99e-05	0.000257	CbGpPWpGaD
Topiramate—CA5B—Metabolism—ALB—liver cancer	7.99e-05	0.000257	CbGpPWpGaD
Topiramate—CA1—Metabolism—CYP1A1—liver cancer	7.98e-05	0.000257	CbGpPWpGaD
Topiramate—CA9—Metabolism—HMOX1—liver cancer	7.94e-05	0.000256	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARA—liver cancer	7.94e-05	0.000256	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTP1—liver cancer	7.92e-05	0.000255	CbGpPWpGaD
Topiramate—GABRA1—SIDS Susceptibility Pathways—IL6—liver cancer	7.83e-05	0.000252	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	7.82e-05	0.000252	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—CTNNB1—liver cancer	7.76e-05	0.00025	CbGpPWpGaD
Topiramate—CA2—Metabolism—MTHFR—liver cancer	7.76e-05	0.00025	CbGpPWpGaD
Topiramate—GABRG2—Transmission across Chemical Synapses—HRAS—liver cancer	7.67e-05	0.000247	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—TAT—liver cancer	7.65e-05	0.000247	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARA—liver cancer	7.61e-05	0.000245	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—MMP9—liver cancer	7.61e-05	0.000245	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CB—liver cancer	7.55e-05	0.000243	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CB—liver cancer	7.55e-05	0.000243	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	7.53e-05	0.000243	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CD—liver cancer	7.49e-05	0.000242	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—PPARA—liver cancer	7.46e-05	0.00024	CbGpPWpGaD
Topiramate—CA1—Metabolism—MTHFR—liver cancer	7.44e-05	0.00024	CbGpPWpGaD
Topiramate—CA9—Metabolism—GSTM1—liver cancer	7.4e-05	0.000238	CbGpPWpGaD
Topiramate—CA12—Metabolism—ALB—liver cancer	7.4e-05	0.000238	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARA—liver cancer	7.3e-05	0.000235	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—GSTM1—liver cancer	7.28e-05	0.000235	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	7.18e-05	0.000232	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CB—liver cancer	7.05e-05	0.000227	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CB—liver cancer	7.05e-05	0.000227	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—HRAS—liver cancer	7.02e-05	0.000226	CbGpPWpGaD
Topiramate—CA9—Metabolism—CYP1A1—liver cancer	7.01e-05	0.000226	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—ALB—liver cancer	6.94e-05	0.000224	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—HRAS—liver cancer	6.92e-05	0.000223	CbGpPWpGaD
Topiramate—CYP3A4—Biological oxidations—CYP1A1—liver cancer	6.9e-05	0.000223	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—VEGFA—liver cancer	6.83e-05	0.00022	CbGpPWpGaD
Topiramate—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	6.81e-05	0.000219	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CG—liver cancer	6.8e-05	0.000219	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—STAT3—liver cancer	6.76e-05	0.000218	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—IL6—liver cancer	6.72e-05	0.000217	CbGpPWpGaD
Topiramate—GABRA1—Transmission across Chemical Synapses—HRAS—liver cancer	6.7e-05	0.000216	CbGpPWpGaD
Topiramate—SCN5A—Axon guidance—IL6—liver cancer	6.62e-05	0.000213	CbGpPWpGaD
Topiramate—CA4—Metabolism—PPARG—liver cancer	6.56e-05	0.000211	CbGpPWpGaD
Topiramate—CA9—Metabolism—MTHFR—liver cancer	6.54e-05	0.000211	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CB—liver cancer	6.53e-05	0.000211	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CG—liver cancer	6.52e-05	0.00021	CbGpPWpGaD
Topiramate—GABRB2—Neuronal System—HRAS—liver cancer	6.42e-05	0.000207	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARA—liver cancer	6.41e-05	0.000207	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—ALB—liver cancer	6.34e-05	0.000204	CbGpPWpGaD
Topiramate—CA2—Metabolism—PPARG—liver cancer	6.29e-05	0.000203	CbGpPWpGaD
Topiramate—GABRB2—Transmembrane transport of small molecules—RAF1—liver cancer	6.27e-05	0.000202	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TGFB1—liver cancer	6.27e-05	0.000202	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CG—liver cancer	6.25e-05	0.000201	CbGpPWpGaD
Topiramate—SCN1A—Developmental Biology—AKT1—liver cancer	6.2e-05	0.0002	CbGpPWpGaD
Topiramate—CA1—Metabolism—PPARG—liver cancer	6.03e-05	0.000194	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CD—liver cancer	5.98e-05	0.000193	CbGpPWpGaD
Topiramate—CA4—Metabolism—ALB—liver cancer	5.9e-05	0.00019	CbGpPWpGaD
Topiramate—GABRG2—Neuronal System—HRAS—liver cancer	5.88e-05	0.000189	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—TNF—liver cancer	5.85e-05	0.000189	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—KRAS—liver cancer	5.81e-05	0.000187	CbGpPWpGaD
Topiramate—GABRG2—Transmembrane transport of small molecules—RAF1—liver cancer	5.74e-05	0.000185	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CD—liver cancer	5.73e-05	0.000185	CbGpPWpGaD
Topiramate—CA2—Metabolism—ALB—liver cancer	5.66e-05	0.000182	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	5.63e-05	0.000182	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—ALB—liver cancer	5.54e-05	0.000179	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CG—liver cancer	5.49e-05	0.000177	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CD—liver cancer	5.49e-05	0.000177	CbGpPWpGaD
Topiramate—CA1—Metabolism—ALB—liver cancer	5.42e-05	0.000175	CbGpPWpGaD
Topiramate—CA9—Metabolism—PPARG—liver cancer	5.3e-05	0.000171	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CB—liver cancer	5.21e-05	0.000168	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CPT1B—liver cancer	5.2e-05	0.000168	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GLUL—liver cancer	5.2e-05	0.000168	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—UGDH—liver cancer	5.16e-05	0.000166	CbGpPWpGaD
Topiramate—GABRA1—Neuronal System—HRAS—liver cancer	5.14e-05	0.000166	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NR1H4—liver cancer	5.02e-05	0.000162	CbGpPWpGaD
Topiramate—GABRA1—Transmembrane transport of small molecules—RAF1—liver cancer	5.01e-05	0.000162	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CB—liver cancer	4.99e-05	0.000161	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—HRAS—liver cancer	4.93e-05	0.000159	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA3—liver cancer	4.93e-05	0.000159	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—EPT1—liver cancer	4.85e-05	0.000156	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CD—liver cancer	4.83e-05	0.000156	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CB—liver cancer	4.79e-05	0.000154	CbGpPWpGaD
Topiramate—CA9—Metabolism—ALB—liver cancer	4.77e-05	0.000154	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—IL6—liver cancer	4.72e-05	0.000152	CbGpPWpGaD
Topiramate—CA5A—Metabolism—PIK3CA—liver cancer	4.6e-05	0.000148	CbGpPWpGaD
Topiramate—CA6—Metabolism—PIK3CA—liver cancer	4.6e-05	0.000148	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—TAT—liver cancer	4.6e-05	0.000148	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA4—liver cancer	4.51e-05	0.000145	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	4.41e-05	0.000142	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA2—liver cancer	4.4e-05	0.000142	CbGpPWpGaD
Topiramate—SCN5A—Developmental Biology—AKT1—liver cancer	4.36e-05	0.00014	CbGpPWpGaD
Topiramate—CA5B—Metabolism—PIK3CA—liver cancer	4.3e-05	0.000139	CbGpPWpGaD
Topiramate—CA7—Metabolism—PIK3CA—liver cancer	4.3e-05	0.000139	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTA1—liver cancer	4.24e-05	0.000137	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CB—liver cancer	4.21e-05	0.000136	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—NAT2—liver cancer	4.19e-05	0.000135	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.03e-05	0.00013	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALDOB—liver cancer	4.02e-05	0.00013	CbGpPWpGaD
Topiramate—CA12—Metabolism—PIK3CA—liver cancer	3.98e-05	0.000128	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CRABP1—liver cancer	3.84e-05	0.000124	CbGpPWpGaD
Topiramate—CA6—Metabolism—AKT1—liver cancer	3.76e-05	0.000121	CbGpPWpGaD
Topiramate—CA5A—Metabolism—AKT1—liver cancer	3.76e-05	0.000121	CbGpPWpGaD
Topiramate—CA7—Metabolism—AKT1—liver cancer	3.51e-05	0.000113	CbGpPWpGaD
Topiramate—CA5B—Metabolism—AKT1—liver cancer	3.51e-05	0.000113	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	3.45e-05	0.000111	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HPGDS—liver cancer	3.35e-05	0.000108	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.33e-05	0.000107	CbGpPWpGaD
Topiramate—CA12—Metabolism—AKT1—liver cancer	3.25e-05	0.000105	CbGpPWpGaD
Topiramate—CA4—Metabolism—PIK3CA—liver cancer	3.18e-05	0.000102	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CPT1B—liver cancer	3.13e-05	0.000101	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GLUL—liver cancer	3.13e-05	0.000101	CbGpPWpGaD
Topiramate—CA2—Metabolism—PIK3CA—liver cancer	3.04e-05	9.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.04e-05	9.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NR1H4—liver cancer	3.02e-05	9.72e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	3e-05	9.66e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMA4—liver cancer	2.99e-05	9.63e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PSMD10—liver cancer	2.99e-05	9.63e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA3—liver cancer	2.97e-05	9.56e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—PIK3CA—liver cancer	2.92e-05	9.41e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GOT2—liver cancer	2.91e-05	9.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP2E1—liver cancer	2.73e-05	8.81e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA4—liver cancer	2.71e-05	8.74e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	2.65e-05	8.53e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA2—liver cancer	2.64e-05	8.52e-05	CbGpPWpGaD
Topiramate—CA4—Metabolism—AKT1—liver cancer	2.59e-05	8.36e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—PIK3CA—liver cancer	2.57e-05	8.27e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYCS—liver cancer	2.56e-05	8.24e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTA1—liver cancer	2.55e-05	8.22e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—NAT2—liver cancer	2.52e-05	8.13e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GOT1—liver cancer	2.51e-05	8.09e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GGT1—liver cancer	2.51e-05	8.09e-05	CbGpPWpGaD
Topiramate—CA2—Metabolism—AKT1—liver cancer	2.49e-05	8.02e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALDOB—liver cancer	2.42e-05	7.79e-05	CbGpPWpGaD
Topiramate—CA1—Metabolism—AKT1—liver cancer	2.38e-05	7.69e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CRABP1—liver cancer	2.31e-05	7.43e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTP1—liver cancer	2.25e-05	7.26e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—HMOX1—liver cancer	2.22e-05	7.16e-05	CbGpPWpGaD
Topiramate—CA9—Metabolism—AKT1—liver cancer	2.1e-05	6.76e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—GSTM1—liver cancer	2.07e-05	6.68e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HPGDS—liver cancer	2.02e-05	6.5e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—CYP1A1—liver cancer	1.96e-05	6.33e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—MTHFR—liver cancer	1.83e-05	5.9e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMA4—liver cancer	1.8e-05	5.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PSMD10—liver cancer	1.8e-05	5.79e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARA—liver cancer	1.8e-05	5.79e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GOT2—liver cancer	1.75e-05	5.63e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP2E1—liver cancer	1.64e-05	5.3e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.61e-05	5.2e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CG—liver cancer	1.54e-05	4.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYCS—liver cancer	1.54e-05	4.96e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GOT1—liver cancer	1.51e-05	4.86e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GGT1—liver cancer	1.51e-05	4.86e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PPARG—liver cancer	1.48e-05	4.78e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTP1—liver cancer	1.36e-05	4.37e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CD—liver cancer	1.35e-05	4.36e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—HMOX1—liver cancer	1.34e-05	4.31e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—ALB—liver cancer	1.33e-05	4.3e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—GSTM1—liver cancer	1.25e-05	4.01e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—CYP1A1—liver cancer	1.18e-05	3.81e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CB—liver cancer	1.18e-05	3.8e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—MTHFR—liver cancer	1.1e-05	3.55e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARA—liver cancer	1.08e-05	3.48e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CG—liver cancer	9.25e-06	2.98e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PPARG—liver cancer	8.92e-06	2.88e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CD—liver cancer	8.13e-06	2.62e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—ALB—liver cancer	8.03e-06	2.59e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—PIK3CA—liver cancer	7.18e-06	2.32e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CB—liver cancer	7.09e-06	2.28e-05	CbGpPWpGaD
Topiramate—CYP2C19—Metabolism—AKT1—liver cancer	5.87e-06	1.89e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—PIK3CA—liver cancer	4.32e-06	1.39e-05	CbGpPWpGaD
Topiramate—CYP3A4—Metabolism—AKT1—liver cancer	3.53e-06	1.14e-05	CbGpPWpGaD
